These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 17644843)
41. My doctor has me taking Lopid (gemfibrozil) twice a day. My cholesterol level is only 187, but my HDL cholesterol is low at 25. My LDL cholesterol is"normal" at 98 and my triglycerides are 318. These pills give me stomach cramps and they are expensive. Do I need to take them? Harv Heart Lett; 1998 Aug; 8(12):8. PubMed ID: 9713237 [No Abstract] [Full Text] [Related]
42. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice. van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886 [TBL] [Abstract][Full Text] [Related]
43. [Diabetic dyslipoproteinemia: beyond LDL]. Merkel M Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932 [TBL] [Abstract][Full Text] [Related]
44. Simcor: a niacin/simvastatin combination. Med Lett Drugs Ther; 2008 Apr; 50(1283):25-6. PubMed ID: 18391898 [No Abstract] [Full Text] [Related]
45. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2. Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW; Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709 [TBL] [Abstract][Full Text] [Related]
46. Niacin: its value in raising HDL cholesterol is being questioned. Heart Advis; 2011 Oct; 14(10):7. PubMed ID: 23019714 [No Abstract] [Full Text] [Related]
47. Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification. Sang ZC; Wang F; Zhou Q; Li YH; Li YG; Wang HP; Chen SY Chin Med J (Engl); 2009 Jul; 122(14):1615-20. PubMed ID: 19719960 [TBL] [Abstract][Full Text] [Related]
48. What about Niacin? Medical Letter Med Lett Drugs Ther; 2011 Nov; 53(1378):93-4. PubMed ID: 22113122 [No Abstract] [Full Text] [Related]
49. I've read that I should lower my triglycerides as well as my cholesterol. What's the difference, and what should I do to lower them? Health News; 2005 Sep; 11(9):16. PubMed ID: 16208815 [No Abstract] [Full Text] [Related]
50. Dyslipidaemia in diabetic patients: time for a rethink. Shepherd J Diabetes Obes Metab; 2007 Sep; 9(5):609-16. PubMed ID: 17697054 [TBL] [Abstract][Full Text] [Related]
52. [Use of prolonged-release nicotinic acid in patients treated with statins as a secondary prevention and a persistently low HDL-cholesterol level in France]. Paillard F; Mosnier M Ann Cardiol Angeiol (Paris); 2008 Apr; 57(2):121-6. PubMed ID: 18394585 [TBL] [Abstract][Full Text] [Related]
53. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. Grover SA; Kaouache M; Joseph L; Barter P; Davignon J Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435 [TBL] [Abstract][Full Text] [Related]
55. Choice of cholesterol-lowering drugs. The Medical Letter. Conn Med; 1988 Nov; 52(11):671-3. PubMed ID: 3233971 [No Abstract] [Full Text] [Related]
56. Ask the doctor. My doctor and I are confused by my cholesterol levels. My good cholesterol is extraordinarily high, at 94, but my bad cholesterol is on the high side, too, at 154. To resolve this good news/bad news story, my doctor ordered a C-reactive protein test which, of course, came back right in the middle of the normal range. I don't smoke or have other factors for heart disease. Would you advise me at start a statin or some other drug? Lee T Harv Heart Lett; 2006 Apr; 16(8):8. PubMed ID: 19681197 [No Abstract] [Full Text] [Related]
58. [Even if LDL and triglycerides are within normal limits, low HDL increases risk of infarction]. MMW Fortschr Med; 2004 May; 146(21):59. PubMed ID: 15373089 [No Abstract] [Full Text] [Related]
59. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Hou R; Goldberg AC Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513 [TBL] [Abstract][Full Text] [Related]